Arena and Vivus Take Divergent Paths To CRL Response
Lorqess and Qnexa both have received "complete responses" from FDA, but the drastically different contents of the letters have shaped divergent responses from the drugs' sponsors.
Lorqess and Qnexa both have received "complete responses" from FDA, but the drastically different contents of the letters have shaped divergent responses from the drugs' sponsors.